Oncology Data Advisor

04/30/2026

Groundbreaking prostate cancer data from 2026 includes advancements in combination therapies, PSMA-targeted T-cell engagers, and treatment intensification strategies.

Dr. Stephen Freedland and Dr. Alicia Morgans recap the findings shaping the future of care:

ASCO Genitourinary Cancers Symposium 2026: Prostate Cancer Recap

04/02/2026

Don't let the latest breakthroughs pass you by! Whether you're at the gym, in the car, or at home, the Oncology Data Advisor makes it easy to stay informed.

Join our community of providers who are turning the newest research into better real-world care every day.

🎧 Find us on Spotify, Apple Podcasts, and more: bit.ly/4tRZuWY

01/01/2026

Happy New Year from OncData! 🎉 Thank you for being part of our community and for your commitment to advancing healthcare. Wishing you a healthy and inspiring year ahead!

12/25/2025

Merry Christmas from Oncology Data. Advisor! 🎄May your holiday season be bright, and we look forward to connecting with you again in the new year.

12/20/2025

Happy Holidays from Oncology Data Advisor! We’re honored to support your work with insights, education, and data that make a difference for patients every day. Wishing you peace, joy, and a healthy new year.

11/13/2025

Oncology Data Advisor is proud to announce Matthew Hadfield, DO, as Editor in Chief.

Dr. Hadfield, Medical Oncologist and Assistant Professor of Medicine at Brown University/Legorreta Cancer Center, specializes in melanoma, early drug development, and immunotherapy-related adverse event management.

Read more here: https://bit.ly/4i1uCxV

10/11/2025

FDA approval of imlunestrant is a milestone for advanced breast cancer with ESR1 mutations.

Dr. Komal Jhaveri, lead author of the EMBER-3 trial, shares insights on its impact during Breast Cancer Awareness Month.

Read more here: https://bit.ly/3KwWVaJ

09/13/2025

Transitioning from oncology fellowship to an attending role is a pivotal milestone filled with challenges and rewards.

In this article, Dr. Matthew Hadfield and Dr. Alankrita Taneja reflect on their first year in independent practice, sharing insights on decision-making, mentorship, non-clinical responsibilities, and the most rewarding aspects of patient care.

Read more here: https://bit.ly/48hYiDV

08/24/2025

☀️ As we recognize Summer Sun Safety Month, Dr. Matthew Hadfield, Medical Oncologist at Brown University, shares practical guidance on UV biology, the role of sunscreens, and actionable strategies for cancer prevention.

Learn how to counsel diverse patient populations, monitor for skin cancer, and emphasize the power of prevention.

Watch the full interview: https://bit.ly/3UHVF6r

08/21/2025

The FDA has granted accelerated approval to dordaviprone (Modeyso™), the first systemic therapy for H3 K27M–mutant diffuse midline glioma.

This approval provides a critical option for adult and pediatric patients with progressive disease after prior therapy, addressing a significant unmet need.

Learn more about the clinical trials, efficacy, and safety of this groundbreaking treatment: https://bit.ly/4mBMEYl

08/15/2025

Genetic testing and counseling are transforming cancer care.

In this follow-up interview to Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, Dr. Filipa Lynce and Catherine Skefos share updates on RNA testing, clinical trials like OlympiA, and strategies to improve patient outcomes.

Watch here: https://bit.ly/45Obxuj

08/14/2025

Explore the intersection of technology and cancer care in the latest edition of The Way Ahead with Dr. Waqas Haque.

Learn how cutting-edge AI is revolutionizing drug discovery, achieving up to 90% success rates in early trials, and how structured social interventions, like the CHALLENGE trial’s exercise program, are transforming patient outcomes.

Discover the balance between innovation and human oversight in healthcare: https://bit.ly/3HdfGie